Polyrizon Ltd. business relationships
Companies named in Polyrizon Ltd.’s 20-F filed 2026-03-25, and public companies whose annual reports name Polyrizon Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 8 / 100 Top 2% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in Polyrizon Ltd.’s annual report 2
“to the terms of the SciSparc License Agreement, SciSparc is entitled to up to $3.32 million based on the achievement of certain milestones,” SEC filing
“In accordance with the collaboration agreement, SciSparc will pay development fees to the Company upon successful completion of clinical trials, of $ 80 by successful completion of preclinical safety tests, $ 120 by successful completion of Phase 1 clinical trial, $ 150 by upon successful completion...” SEC filing
Companies whose annual reports name Polyrizon Ltd. 3
“On August 13, 2024, the Company entered into the license agreement (the "License Agreement") of the out-licensing of its SCI-160 program (the "Assets"), with Polyrizon Ltd. (the "Licensee" or "Polyrizon").” SEC filing
“In addition, in August 2024, we entered into an exclusive patent license agreement with Polyrizon Ltd.,” SEC filing
“into a collaboration agreement with Polyrizon, a biotech company focused on the development of innovative medical device hydrogels delivered” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.